CytoResc – “CytoSorb” Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial

Abstract Objectives Approximately 8 - 10 % of COVID-19 patients present with a serious clinical course and need for hospitalization, 8% of hospitalized patients need ICU-treatment. Currently, no causal therapy is available and treatment is purely supportive. The main reason for death in critically i...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Helena Stockmann, Theresa Keller, Stefan Büttner, Achim Jörres, Detlef Kindgen-Milles, Julius Valentin Kunz, Josef Leebmann, Claudia Spies, Karl Träger, Sascha Treskatsch, Alexander Uhrig, Carsten Willam, Philipp Enghard, Torsten Slowinski, for the CytoResc Trial Investigators
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2020-06-01
Colecção:	Trials
Assuntos:	COVID-19 Randomized controlled trial protocol cytokine storm vasoplegic shock extracorporeal cytokine elimination
Acesso em linha:	http://link.springer.com/article/10.1186/s13063-020-04501-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!